Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study

Home > Science Hub > Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
Back to the list

November 16, 2023

You might also be interested by

Press Releases

CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development

July 15, 2026

More info

CellTalk Blog

B-Cell Monitoring in Autoimmune Programs: Expert Insights

June 30, 2026

More info

CellTalk Blog

CAR Kinetics in Autoimmune Studies: Expert Insights on Designing Effective Monitoring Strategies

June 30, 2026

More info

CellTalk Blog

Cytokine Profiling in Autoimmune Programs: Expert Insights on Assay Selection and Getting Data You Can Trust

June 30, 2026

More info